BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8061340)

  • 21. Serum levels of soluble interleukin-2 receptor (sIL-2R) in B-chronic lymphocytic leukemia.
    Cacciola E; Calogero D; Marra G; Guglielmo P
    Boll Soc Ital Biol Sper; 1992 Apr; 68(4):259-62. PubMed ID: 1463600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
    Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
    Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA; Hill RB; Heldman L; Ramakrishnan S
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
    Duan ZF
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The level of interleukin-2 and of soluble interleukin-2 receptor in patients with Balkan nephropathy.
    Vöö S; Drugărin D; Mărgineanu F; Koreck A; Negru S; Biriescu A
    Roum Arch Microbiol Immunol; 2002; 61(3):207-16. PubMed ID: 14752984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies.
    Nakase K; Tsuji K; Tamaki S; Tanigawa M; Ikeda T; Miyanishi E; Shiku H
    Cancer Detect Prev; 2005; 29(3):256-9. PubMed ID: 15899555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
    Mehta R; Shah G; Adler W; Kittur D
    Clin Transplant; 2004; 18 Suppl 12():67-71. PubMed ID: 15217411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis.
    Dejica D; Treichel U; Pár A; Chira O; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1997 Jan; 35(1):15-21. PubMed ID: 9123953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum levels of soluble CD25 (soluble interleukin 2 receptor) in asthmatic patients].
    Shiota Y; Sato T; Ono T
    Arerugi; 1993 Aug; 42(8):914-9. PubMed ID: 8250731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of elevated serum soluble interleukin-2 receptor in gastric cancer.
    Wang YF; Wu XN; Zhou YH; Chen XF; Shen J; Wang HJ
    Chin Med J (Engl); 1994 Apr; 107(4):254-6. PubMed ID: 8088190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C reactive protein in pancreatic cancer and chronic pancreatitis.
    Basso D; Fabris C; Meani A; Del Favero G; Vianello D; Angonese C; Meggiato T; Bellinvia S; Fogar P; Petrin P
    Ann Clin Res; 1988; 20(6):414-6. PubMed ID: 3218913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
    Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
    Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.
    Zerler B
    Cancer Cells; 1991 Dec; 3(12):471-9. PubMed ID: 1820093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a new immunoassay for determining serum pancreatic isoamylase with two standard techniques.
    Ventrucci M; Pezzilli R; Gullo L
    Am J Gastroenterol; 1990 Oct; 85(10):1381-5. PubMed ID: 2220732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations.
    Alexander AG; Barnes NC; Kay AB; Corrigan CJ
    Eur Respir J; 1995 Apr; 8(4):574-8. PubMed ID: 7664856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of increased serum soluble interleukin-2 receptor levels in patients with pulmonary tuberculosis].
    Chui JJ; Fan P; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):288-90, 318-9. PubMed ID: 7712570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy.
    Mandreoli M; Beltrandi E; Casadei-Maldini M; Mancini R; Zucchelli A; Zucchelli P
    Clin Nephrol; 1992 Apr; 37(4):177-82. PubMed ID: 1582055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.